Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the molecular formula C17H27NO4 and a molecular weight of approximately 309.41 g/mol[1][2][9]. It is listed in chemical and drug databases as an experimental or candidate drug but does not have an established clinical use or approved indication. The structure features an isoindole core substituted with butoxy and formylpropyl groups. There is no publicly available information on its mechanism of action or therapeutic target; however it has been referenced as a ligand in protein structural studies[3][8] and appears in patent literature for potential pharmaceutical applications[6]. No evidence suggests it has reached advanced clinical development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (1S,4R,7AR)-4-butoxy-1-[(1R)-1-formylpropyl]-2,4,5,6,7,7a-hexahydro-1H-isoindole-3-carboxylic acid.